New York S 9172: Relates to direct access laboratory testing for certain lipid screening assays

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S09172 Summary:

BILL NOS09172 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORFAHY

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add §579-a, Pub Health L

&nbsp

Provides that clinical laboratories may provide laboratory testing at the request of individuals, without a practitioner order or prescription, for certain types of cholesterol.

Go to top S09172 Actions:

BILL NOS09172 

&nbsp

02/10/2026REFERRED TO HEALTH

Go to topS09172 Committee&nbspVotes:

Go to topS09172 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS09172 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 9172

 IN SENATE

 February 10, 2026
 ___________

 Introduced by Sen. FAHY -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to direct access
 laboratory testing for certain lipid screening assays

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 579-a to read as follows:
 3 § 579-a. Direct access laboratory testing for certain lipid screening
 4 assays. 1. Authorization. Notwithstanding any other provision of law, a
 5 clinical laboratory licensed pursuant to this article may perform labo-
 6 ratory testing, at the request of an individual and without a practi-
 7 tioner order or prescription, limited to the following assays: low-den-
 8 sity lipoprotein cholesterol (LDL-C), including direct measurement or
 9 calculated HDL cholesterol, LDL cholesterol, triglycerides, total
 10 cholesterol, and lipoprotein(a) (Lp(a)).
 11 2. Laboratory requirements. A clinical laboratory performing testing
 12 pursuant to this section shall:
 13 (a) provide the test results to the subject of the test in a clear and
 14 understandable format; and
 15 (b) comply with all applicable requirements of this article, regu-
 16 lations promulgated thereunder, and the federal clinical laboratory
 17 improvement amendments of 1988 (CLIA).
 18 3. Limitations. Nothing in this section shall be construed to:
 19 (a) authorize the diagnosis or treatment of any disease or condition
 20 by a clinical laboratory;
 21 (b) expand or alter the scope of practice of any licensed health care
 22 profession; or
 23 (c) permit direct access laboratory testing without a practitioner
 24 order for any assay other than those expressly identified under subdivi-
 25 sion one of this section.
 26 § 2. This act shall take effect on the one hundred eightieth day after
 27 it shall have become a law. Effective immediately, the commissioner of
 28 health is authorized to take any actions necessary to implement this act
 29 on or before such effective date.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD14382-02-6

Go to top 

• 

 Sitemap 

 Request Information 

 Directions and Maps